1. Extra-intestinal manifestations of inflammatory bowel diseases;Marotto;Pharm. Res.,2020
2. A.N. Ananthakrishnan, G.G. Kaplan, C.N. Bernstein, K.E. Burke, P.J. Lochhead, A.N. Sasson, M. Agrawal, J.H.T. Tiong, J. Steinberg, W. Kruis, F. Steinwurz, V. Ahuja, S.C. Ng, D.T. Rubin, J.F. Colombel, R. Gearry, D. International Organization for Study of Inflammatory Bowel, Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus, Lancet Gastroenterol Hepatol (2022).
3. Emerging pharmacotherapy for inflammatory bowel diseases;Luo;Pharm. Res.,2022
4. Biological therapy in pediatric age;Penagini;Pharm. Res.,2020
5. Inflammatory bowel disease - non-biological treatment;Magro;Pharm. Res.,2020